Form D · Biotechnology
JoJo Biotechnologies Co Ltd
Hongkong, K3 · CIK 0002065903
Offering snapshot reported Apr 28, 2025 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-544597
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| bigc securities,inc. | None |
Source: Form D, filed Apr 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dai Qiaofu | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Rm D07,8/F Kai Tak Fty Bldg No. 99 King Fuk St San Po Kong Hong Kong
Hongkong, K3, 999077
Hongkong, K3, 999077